ALADDIN Study: Antigonadotropin-Leuprolide in Alzheimer's Disease Drug INvestigation

Clinical trial NCT00063310 · COMPLETED

Trial details

NCT number: NCT00063310
Sponsor: Voyager Pharmaceutical Corporation
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Alzheimer Disease

Start date: 2003-03-01
Primary completion: 2006-02-01
Enrollment: 90

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.